0.0142
-0.0003 (-2.07%)
-0.0003 (-2.07%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
Small Cap Pro
Monthly Subscription
for only
|
Canna Trader Pro
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
AngioSoma Inc (PK) | SOAN | OTCMarkets | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
-0.0003 | -2.07% | 0.0142 | 16:28:40 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0145 | 0.01215 | 0.0145 | 0.0142 | 0.0145 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
0.0134 | 0.0142 | 0.0008 | - | - |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
191 | 8,815,105 | $ 0.013053 | $ 115,064 | - | 0.0006 - 0.0177 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:59:24 | 30,000 | $ 0.0142 | USD |
AngioSoma (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 6.47M | 455.49M | 12.49M | $ - | $ - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
88.29k | $ - | 0.00% | - | - |
AngioSoma (PK) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SOAN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0107 | 0.0177 | 0.0092 | 0.0134689 | 20,542,776 | 0.0035 | 32.71% |
1 Month | 0.0065 | 0.0177 | 0.0053 | 0.0104038 | 11,637,431 | 0.0077 | 118.46% |
3 Months | 0.00685 | 0.0177 | 0.00495 | 0.0085695 | 7,392,104 | 0.00735 | 107.3% |
6 Months | 0.0031 | 0.0177 | 0.00135 | 0.0063949 | 9,447,004 | 0.0111 | 358.06% |
1 Year | 0.0042 | 0.0177 | 0.0006 | 0.0039843 | 9,017,059 | 0.01 | 238.1% |
3 Years | 0.02214 | 0.1265 | 0.0006 | 0.0057952 | 4,272,789 | -0.00794 | -35.86% |
5 Years | 0.185 | 0.52 | 0.0006 | 0.00678 | 2,702,790 | -0.1708 | -92.32% |
AngioSoma (PK) Description
AngioSoma, Inc., is an American biotechnology company originally organized in 2011, headquartered in Houston, Texas with offices in the State of Washington, focused on developing innovative therapies for people with serious and life-threating rare disorders. The Company patented and sold for $10 million of preferred shares a treatment for peripheral artery disease (PAD) called LiprostinTM followed by acquiring an exclusive license for a patented method of treating neurodegenerative diseases such as Multiple Sclerosis by administering a synergistically effective amount of the composition to an individual suffering from neurodegeneration and treating neurodegeneration. We are in discussions with several contract research organizations to assist with our submission of new drug application for global marketing. |